Pictet Asset Management Holding SA Acquires 11,980 Shares of Tempus AI, Inc. $TEM

Pictet Asset Management Holding SA boosted its holdings in Tempus AI, Inc. (NASDAQ:TEM) by 24.7% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 60,468 shares of the company’s stock after buying an additional 11,980 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Tempus AI were worth $2,603,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPL Wealth Management LLC acquired a new position in Tempus AI during the third quarter worth about $26,000. Los Angeles Capital Management LLC bought a new stake in shares of Tempus AI during the 4th quarter valued at approximately $27,000. Harvest Fund Management Co. Ltd bought a new stake in shares of Tempus AI during the 3rd quarter valued at approximately $38,000. Lodestone Wealth Management LLC acquired a new position in Tempus AI during the 4th quarter worth approximately $42,000. Finally, CoreCap Advisors LLC increased its position in Tempus AI by 135.1% during the 4th quarter. CoreCap Advisors LLC now owns 743 shares of the company’s stock worth $44,000 after purchasing an additional 427 shares in the last quarter. Institutional investors own 24.22% of the company’s stock.

Wall Street Analyst Weigh In

TEM has been the subject of several research reports. Freedom Capital raised shares of Tempus AI to a “hold” rating in a research note on Tuesday, June 30th. HC Wainwright lowered their price target on shares of Tempus AI from $95.00 to $64.00 and set a “buy” rating for the company in a report on Monday, May 11th. Wolfe Research began coverage on Tempus AI in a research note on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Wall Street Zen downgraded Tempus AI from a “hold” rating to a “sell” rating in a report on Saturday. Finally, BTIG Research restated a “buy” rating and set a $80.00 price objective on shares of Tempus AI in a research report on Monday, June 1st. Nine research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $68.54.

Tempus AI Price Performance

Shares of NASDAQ TEM opened at $60.27 on Monday. The company has a 50 day simple moving average of $50.48 and a 200 day simple moving average of $54.47. The company has a debt-to-equity ratio of 2.96, a current ratio of 3.31 and a quick ratio of 3.15. Tempus AI, Inc. has a 1 year low of $41.73 and a 1 year high of $104.32. The firm has a market cap of $10.82 billion, a PE ratio of -35.04 and a beta of 3.46.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings data on Tuesday, May 5th. The company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.08. The business had revenue of $348.12 million during the quarter, compared to the consensus estimate of $345.44 million. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.Tempus AI’s quarterly revenue was up 36.1% on a year-over-year basis. During the same period in the prior year, the business posted ($0.24) earnings per share. On average, research analysts forecast that Tempus AI, Inc. will post -1.35 EPS for the current year.

Insider Buying and Selling

In related news, CEO Ryan Fukushima sold 13,550 shares of the company’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $44.07, for a total transaction of $597,148.50. Following the sale, the chief executive officer owned 603,558 shares in the company, valued at $26,598,801.06. This represents a 2.20% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO James William Rogers sold 11,529 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $55.00, for a total value of $634,095.00. Following the sale, the chief financial officer directly owned 114,866 shares of the company’s stock, valued at $6,317,630. This represents a 9.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 572,759 shares of company stock worth $29,238,424 over the last three months. Insiders own 24.26% of the company’s stock.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.